YY1 inactivated transcription co-regulator PGC-1a to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis ( Apr, 10.1007/s10565-022-09711-7, 2022)

被引:1
作者
Yang, Tingting [1 ]
Hu, Yinlu [1 ]
Chen, Shangxiu [1 ]
Li, Lin [1 ]
Cao, Xinyun [1 ]
Yuan, Jiayu [1 ]
Shu, Fanglin [2 ]
Jiang, Zhenzhou [3 ]
Qian, Sitong [1 ]
Zhu, Xia [1 ]
Wei, Chujing [3 ]
Wei, Rui [1 ]
Yan, Meng [1 ]
Li, Chenlin [1 ]
Yin, Xiaoxing [1 ,4 ]
Lu, Qian [1 ,4 ]
机构
[1] Xuzhou Med Univ, Clin Pharm, Jiangsu Key Lab New Drug Res, Xuzhou 221004, Peoples R China
[2] First Peoples Hosp Hangzhou Linan Dist, Dept Pharm, Hangzhou 311300, Peoples R China
[3] China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, New Drug Screening Ctr, Nanjing 210009, Peoples R China
[4] Xuzhou Med Univ, Sch Pharm, Dept Clin Pharmacol, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Yin Yang 1; Diabetic nephropathy; Tubulointerstitial fibrosis; Mitochondrial; PGC-1; alpha; Epithelial-mesenchymal transition; YIN YANG 1; EPITHELIAL-MESENCHYMAL TRANSITION; KIDNEY-DISEASE; PROGRESSION; MECHANISMS; MITOPHAGY; RECEPTOR; CELLS;
D O I
10.1007/s10565-023-09802-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The development of diabetic nephropathy (DN) could be promoted by the occurrence of tubulointerstitial fibrosis (TIF), which has a close relationship with mitochondrial dysfunction of renal tubular epithelial cells (RTECs). As a key regulator of metabolic homeostasis, Yin Yang 1 (YY1) plays an important role not only in regulating the fibrosis process but also in maintaining the mitochondrial function of pancreatic beta-cells. However, it was not clear whether YY1 participated in maintaining mitochondrial function of RTECs in early DN-associated TIF. In this study, we dynamically detected mitochondrial functions and protein expression of YY1 in db/db mice and high glucose (HG)-cultured HK-2 cells. Our results showed that comparing with the occurrence of TIF, the emergence of mitochondrial dysfunction of RTECs was an earlier even, besides the up-regulated and nuclear translocated YY1. Correlation analysis showed YY1 expressions were negatively associated with PGC-1 alpha in vitro and in vivo. Further mechanism research demonstrated the formation of mTOR-YY1 heterodimer induced by HG up-regulated YY1, the nuclear translocation of which inactivated PGC-1a by binding to the PGC-1 alpha promoter. Overexpression of YY1 induced mitochondrial dysfunctions in normal glucose-cultured HK-2 cells and 8-weeks-old db/m mice. While, dysfunctional mitochondria induced by HG could be improved by knockdown of YY1. Finally, downregulation of YY1 could retard the progression of TIF by preventing mitochondrial functions, resulting in the improvement of epithelial-mesenchymal transition (EMT) in early DN. These findings suggested that YY1 was a novel regulator of mitochondrial function of RTECs and contributed to the occurrence of early DN-associated TIF.
引用
收藏
页码:2787 / 2792
页数:6
相关论文
共 70 条
[51]   Mitochondrial Dysfunction in the Diabetic Kidney [J].
Sharma, Kumar .
MITOCHONDRIAL DYNAMICS IN CARDIOVASCULAR MEDICINE, 2017, 982 :553-562
[52]   YY1 deficiency in β-cells leads to mitochondrial dysfunction and diabetes in mice [J].
Song, Dalong ;
Yang, Qi ;
Jiang, Xiuli ;
Shan, Aijing ;
Nan, Jingminjie ;
Lei, Ying ;
Ji, He ;
Di, Wei ;
Yang, Tianxiao ;
Wang, Tiange ;
Wang, Weiqing ;
Ning, Guang ;
Cao, Yanan .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 112
[53]   Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection [J].
Srinivasan, Satish ;
Guha, Manti ;
Kashina, Anna ;
Avadhani, Narayan G. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2017, 1858 (08) :602-614
[54]   Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study [J].
Tang, Zhuang-Zhuang ;
Zhang, Yu-Meng ;
Zheng, Ting ;
Huang, Ting-Ting ;
Ma, Teng-Fei ;
Liu, Yao-Wu .
PHYTOMEDICINE, 2020, 78
[55]   Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? [J].
Thomas, MJ ;
Seto, E .
GENE, 1999, 236 (02) :197-208
[56]   The tubular hypothesis of nephron filtration and diabetic kidney disease [J].
Vallon, Volker ;
Thomson, Scott C. .
NATURE REVIEWS NEPHROLOGY, 2020, 16 (06) :317-336
[57]   Brown Adipose YY1 Deficiency Activates Expression of Secreted Proteins Linked to Energy Expenditure and Prevents Diet-Induced Obesity [J].
Verdeguer, Francisco ;
Soustek, Meghan S. ;
Hatting, Maximilian ;
Blaettler, Sharon M. ;
McDonald, Devin ;
Barrow, Joeva J. ;
Puigserver, Pere .
MOLECULAR AND CELLULAR BIOLOGY, 2016, 36 (01) :184-196
[58]   Metabolomics Study of Metabolic Changes in Renal Cells in Response to High-Glucose Exposure Based on Liquid or Gas Chromatography Coupled With Mass Spectrometry [J].
Wang, Liang ;
Dui, Yan ;
Xu, Bing-ju ;
Deng, Xu ;
Liu, Qing-hua ;
Zhong, Qiao-qiao ;
Wang, Chen-xiang ;
Ji, Shuai ;
Guo, Meng-zhe ;
Tang, Dao-quan .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[59]   Quercetin attenuates diabetic neuropathic pain by inhibiting mTOR/p70S6K pathway-mediated changes of synaptic morphology and synaptic protein levels in spinal dorsal horn of db/db mice [J].
Wang, Ruiyao ;
Qiu, Zhuang ;
Wang, Guizhi ;
Hu, Qian ;
Shi, Naihao ;
Zhang, Zongqin ;
Wu, Yuqing ;
Zhou, Chenghua .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 882
[60]   Mitochondrial dysfunction in diabetic kidney disease [J].
Wei, Pascal Zhongping ;
Szeto, Cheuk Chun .
CLINICA CHIMICA ACTA, 2019, 496 :108-116